Plasma LTE4/PGF(2 alpha) Ratio and Blood Eosinophil Count Are Increased in Elderly Asthmatics With Previous Asthma Exacerbation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ban, Ga-Young | - |
dc.contributor.author | Ye, Young-Min | - |
dc.contributor.author | Kim, Sang-Ha | - |
dc.contributor.author | Hur, Gyu-Young | - |
dc.contributor.author | Kim, Joo-Hee | - |
dc.contributor.author | Shim, Jae-Jung | - |
dc.contributor.author | Cho, Kumsun | - |
dc.contributor.author | Cho, Joo-Youn | - |
dc.contributor.author | Park, Hae-Sim | - |
dc.date.accessioned | 2021-09-03T04:26:01Z | - |
dc.date.available | 2021-09-03T04:26:01Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-07 | - |
dc.identifier.issn | 2092-7355 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/82946 | - |
dc.description.abstract | The tools for asthma control assessment recommended by the current guideline are cognitive function- and effort-dependent, which is substantially impaired in the elderly. The aim of this study is to investigate objective assessment tools of asthma control status and previous asthma exacerbation (AE) in elderly subjects. Asthmatics aged >60 years who were treated with step 2 or 3 by the Global Initiative for Asthma (GINA) guideline were enrolled. During the 12-week study period, the subjects used either 400 mu g of budesonide plus 10 mg of montelukast or 800 mu g of inhaled budesonide. The occurrence of AE during the 4-week run-in and 12-week treatment period was monitored. After 12-week of treatment, sputum eosinophil count, peripheral eosinophil count, the plasma leukotriene E-4 (LTE4), and prostaglandin F-2 alpha (PGF(2 alpha)) metabolite levels were measured using the UHPLC/Q-ToF MS system. The study subjects were divided into group 1 (asthmatics who experienced AE during the study period) and group 2 (those who did not). A total of 101 patients aged 60-85 years were enrolled. Twenty-three patients (22.8%) had experienced AE. The plasma LTE4 level, LTE4/PGF(2 alpha) ratio, and peripheral eosinophil count were significantly higher in group 1 than in group 2 (P=0.023, P=0.010, P=0.033, respectively). The plasma LTE4/PGF(2 alpha) ratio and peripheral eosinophil count at week 12 were significantly associated with previous AE (odds ratio [OR]=1.748, P=0.013; OR =1.256, P=0.027). Receiver operating characteristic (ROC) curves to discriminate the subjects with previous AE, including these 2 parameters, showed that the area under the curve was 0.700 (P=0.004), with 73.9% sensitivity and 47.9% specificity. In conclusion, a combination of plasma LTE4/PGF(2 alpha), ratio and peripheral eosinophil count can be an objective assessment tool which is significantly associated with asthma control status in elderly asthmatics. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGY | - |
dc.subject | CYSTEINYL LEUKOTRIENES | - |
dc.subject | CHILDREN | - |
dc.title | Plasma LTE4/PGF(2 alpha) Ratio and Blood Eosinophil Count Are Increased in Elderly Asthmatics With Previous Asthma Exacerbation | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hur, Gyu-Young | - |
dc.contributor.affiliatedAuthor | Shim, Jae-Jung | - |
dc.identifier.doi | 10.4168/aair.2017.9.4.378 | - |
dc.identifier.scopusid | 2-s2.0-85019179155 | - |
dc.identifier.wosid | 000404835300013 | - |
dc.identifier.bibliographicCitation | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, v.9, no.4, pp.378 - 382 | - |
dc.relation.isPartOf | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH | - |
dc.citation.title | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH | - |
dc.citation.volume | 9 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 378 | - |
dc.citation.endPage | 382 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002242347 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Allergy | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalWebOfScienceCategory | Allergy | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.subject.keywordPlus | CYSTEINYL LEUKOTRIENES | - |
dc.subject.keywordPlus | CHILDREN | - |
dc.subject.keywordAuthor | Elderly asthma | - |
dc.subject.keywordAuthor | exacerbation | - |
dc.subject.keywordAuthor | leukotriene | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.